STOCK TITAN

PTCT (NASDAQ: PTCT) insider plans 2,266-share Rule 144 sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider has filed a notice to sell 2,266 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $172,216.00. The planned sale is targeted for 01/05/2026 on the NASDAQ market. These shares were acquired on 01/05/2026 via a stock option originally granted on 01/05/2023, and paid for in cash. In the past three months, the same person sold additional common shares in three transactions totaling several thousand shares, while total shares outstanding are 80,288,305.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many PTCT shares does the insider plan to sell under this notice?

The insider plans to sell 2,266 shares of common stock. The filing lists an aggregate market value of $172,216.00 for this planned sale, with trading expected on NASDAQ through Fidelity Brokerage Services on 01/05/2026.

How were the PTCT shares being sold under Rule 144 acquired?

The 2,266 shares planned for sale were acquired on 01/05/2026 through an option granted on 01/05/2023. The filing states the acquisition was from the issuer and that the purchase price was paid in cash on the acquisition date.

What recent PTCT share sales has the insider made in the last three months?

The insider sold 2,266 shares on 10/06/2025 for $147,453.15, 3,375 shares on 10/07/2025 for $214,094.81, and 2,812 shares on 11/17/2025 for $213,690.35, all listed as common stock transactions.

What is the total number of PTCT shares outstanding referenced in this filing?

The filing states that 80,288,305 shares of common stock are outstanding. This figure provides context for the planned 2,266-share sale and other recent transactions by the insider reported under Rule 144.

Which broker and exchange will handle the insider’s planned PTCT sale?

The planned sale will be executed through Fidelity Brokerage Services LLC, listed at 900 Salem Street, Smithfield, RI 02917. The shares are expected to trade on the NASDAQ exchange, according to the information provided in the notice.

What representation does the insider make about non-public information in this PTCT notice?

By signing the notice, the insider represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required for sales relying on Rule 144.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

6.06B
78.09M
2.47%
101.79%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN